Power delivery IC targets USB Type-C ports

Power delivery IC targets USB Type-C ports Power delivery IC targets USB Type-C ports

The MPQ4242B-AEC1 features an integrated buck-boost converter with four power switches and a USB PD controller.  It is AEC-Q100 Grade 1 qualified and designed for USB Type-C sourcing ports in automotive applications.

This IC supports up to 5-amps of continuous output current (IOUT) over the specified input supply range.

It features a USB Type-C port that supports USB PD revision 3.1 with a programmable power supply (PPS). The MPQ4242B-AEC1 is backward-compatible with dedicated charging port (DCP) schemes for battery charging specification (BC1.2), 3A divider mode, and 1.2V/1.2V mode.

In addition, the device supports QC 2.0/3.0 and the Huawei Fast Charge Protocol (FCP) mode. When battery voltage (VBATT) is low or in the event of over-temperature (OT), the MPQ4242B-AEC1 provides a configurable PD power management state machine.

The MPQ4242B-AEC1 also includes fault condition protections, including input/output (I/O) pin short protection for the BUS and VIN pins, CC overcurrent protection (OCP), current limiting with hiccup mode, output overvoltage protection (OVP), and thermal shutdown.

It is delivered in a QFN-22 (4 x 5 mm2) package and requires readily available, standard external components.

The MPS EVQ4242B-VE-00A evaluation board, also available from Mouser, provides a demonstration and development platform for the MPQ4242B-AEC1. The evaluation board features a pre-mounted MPQ4242B-AEC1, along with the required components and headers enabling access to key signals. The EVQ4242B-VE-00A evaluation board provides an example application circuit, allowing rapid prototyping when incorporated into existing designs.

Keep Up to Date with the Most Important News

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use
Previous Post
Implantable tech could cast new light on bladder cancer treatment

Implantable tech could cast new light on bladder cancer treatment